Stocks Rise, But Biggest Gains Fade – InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Top Stories
Topics
    • Life Insurance News
    • Annuity News
    • Health/Employee Benefits
    • Property and Casualty
    • Advisor News
    • Washington Wire
    • Regulation News
    • Sponsored Articles
    • Monthly Focus
  • INN Exclusives
  • NewsWires
  • Magazine
  • Webinars
  • Free Newsletters
Sign in or register to be an INNsider.
  • Exclusives
  • NewsWires
  • Magazine
  • Webinars
  • Free Newsletters
  • Insider Pro
  • About
  • Advertise
  • Editorial Staff
  • Contact
  • Newsletters

Get Social

  • Facebook
  • Twitter
  • LinkedIn
Advisor News
Top Stories RSS Get our newsletter
Order Prints
April 9, 2018 Top Stories No comments
Share
Share
Tweet
Email

Stocks Rise, But Biggest Gains Fade

Associated Press

NEW YORK (AP) — U.S. stock indexes finished a bit higher Monday as investors let go of some of their fears about a possible trade war between the U.S. and China. But far bigger gains slipped away as the market suffered a steep afternoon decline.

Stocks climbed higher and higher in the first hours of trading, and at about 2 p.m. the Dow Jones industrial average was up 440 points. That put the market on track to make up almost all of the ground it lost during a big sell-off on Friday. But stocks have repeatedly changed course as investors tried to guess the outcome of the U.S.-China trade dispute, and they did it again Monday afternoon.

Health care companies finished with strong gains, and technology companies like Microsoft and Apple regained some of their recent losses. Banks rose along with interest rates. But industrial and retail companies finished with losses, and smaller companies fared worse than larger ones did.

Related stories

  • Jury finds Lexington investment advisor, guilty of charges related to fraud
  • Chicago investment advisor indicted for allegedly swindling clients out of $683,000

"Every day the market wakes up and it struggles with whether it should pay attention to noise or pay attention to fundamentals," said Marina Severinovsky, an investment strategist at Schroders. She said stocks have done well recently when investors can get their minds off the trade disputes because the global economy and the U.S. economy are still growing.

When companies start to report their first-quarter results later this week, she added, the results are likely to be good.

The S&P 500 index gained 8.69 points, or 0.3 percent, to 2,613.16. The S&P 500 fell 1.4 percent last week, with large losses Monday and Friday and strong gains in between.

The Dow Jones industrial average rose 46.34 points, or 0.2 percent, to 23,979.10. The Nasdaq composite jumped 35.23 points, or 0.5 percent, to 6,950.34. The Russell 2000 index of smaller company stocks added 1.17 points, or 0.1 percent, to 1,514.46.

The Russell index is composed of more U.S.-focused companies that are somewhat less vulnerable to the effects of tariffs, so its moves in response to the recent trade tensions haven't been as dramatic.

Most of the stocks on the New York Stock Exchange finished lower Monday.

Investors don't know how the trade dispute might evolve and what it might mean for the global economy. While President Donald Trump continued to bash America's trade deals on Twitter Monday, he said the U.S. and China could settle their dispute. But things looked worse at the end of last week, when Trump threatened to impose tariffs on an additional $100 billion in Chinese goods. China has pledged to "counterattack with great strength" if Trump decides to follow through on that threat. The two nations had already proposed $50 billion in tariffs on imports, but none of that has taken effect yet.

"We don't have a trade war," said Severinovsky, of Schroders. "We have potential suggestions of things that could happen.

Swiss drugmaker Novartis agreed to buy AveXis for $8.7 billion, or $218 a share, as it aims to become a leader in the treatment of neurodegenerative diseases. AveXis is studying a treatment for a disorder called spinal muscular atrophy Type 1, which Novartis called the top genetic cause of death in infants.

AveXis climbed $94.55, or 81.6 percent, to $210.46 and Novartis added 87 cents, or 1.1 percent, to $81.07.

Agribusiness company Monsanto jumped $7.29, or 6.2 percent, to $125.15 after The Wall Street Journal reported that the Department of Justice will approve its sale to German conglomerate Bayer.

This week will be a big one for Facebook as it tries to get its data privacy scandal under control. Facebook CEO Mark Zuckerberg is meeting with legislators and will testify before Congress later this week as the company has embarked on a high profile effort to convince users, advertisers and investors that it is serious about fixing problems that led to the Cambridge Analytica scandal and about user privacy as a whole.

Facebook picked up 73 cents to $157.93. Its stock is down almost 15 percent since March 16.

Facebook's woes have affected other social media companies and big technology companies, including Google's parent company, Alphabet. Severinovsky said investors are considering the possibility that the companies will be regulated in ways they never have been, which will create new costs and affect their earnings. But she thinks they will continue to do well.

"These companies are going to continue to be very profitable," she said.

Bond prices fell. The yield on the 10-year Treasury note rose to 2.78 percent from 2.77 percent late Friday.

Benchmark U.S. crude jumped $1.36, or 2.2 percent, to $63.42 a barrel in New York. Brent crude, used to price international oils, added $1.54, or 2.3 percent, to $68.65 a barrel London.

Wholesale gasoline rose 3 cents to $1.98 a gallon. Heating oil rose 4 cents to $2 a gallon. Natural gas lost 1 cent to $2.69 per 1,000 cubic feet.

Gold rose $4 to $1,340.10 an ounce. Silver gained 17 cents to $16.53 an ounce. Copper picked up 2 cents to $3.08 a pound.

The dollar fell to 106.78 yen from 106.85 yen. The euro rose to $1.2322 from $1.2285.

Germany's DAX rose 0.2 percent and the CAC 40 in France edged up 0.1 percent. The British FTSE 100 added 0.2 percent.

Asian stocks fared better. Tokyo's Nikkei 225 advanced 0.5 percent and Hong Kong's Hang Seng climbed 1.3 percent. Seoul's Kospi added 0.6 percent.

AP Markets Writer Marley Jay can be reached at http://twitter.com/MarleyJayAP . His work can be found at https://apnews.com/search/marley%20jay

Older

Second Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the Company

Newer

BlueCross donates $10.7 million to charities in Tennessee last year

Advisor News

  • Jury finds Lexington investment advisor, guilty of charges related to fraud
  • Chicago investment advisor indicted for allegedly swindling clients out of $683,000
  • Will the family maximum limit my Social Security benefits?
  • South Florida resort sold for $835M, biggest deal for a U.S. hotel since pandemic started
  • Passage of the Secure Act 2.0 brings retirement crisis into focus
More Advisor News

Annuity News

  • $747 million Powerball jackpot still up for grabs
  • Study: Does pessimism really suppress annuity sales?
  • Sweet streams of income: ChatGPT, the bard of annuities
  • F&G Annuities & Life announces equity investment in life IMO SYNCIS
  • Investors scrambling to lock in rates propel annuity sales to record highs
Sponsor
More Annuity News

Health/Employee Benefits News

  • Florida looks to double amount of medical-marijuana licenses
  • Bipartisan group of Missouri lawmakers look to extend healthcare coverage for new moms
  • Medicaid extension for new moms advances amid abortion discussion
  • Medicaid's pandemic benefits are ending
  • Congress has capped Medicare insulin costs. Here’s how it works and what it means
More Health/Employee Benefits News

Life Insurance News

  • In Murdaugh murder trial, the path to conviction remains unclear
  • Libby Murdaugh's caretaker saw Alex night of murders for '20 minutes', but he said '30 to 40'
  • SC judge in Murdaugh murder trial allows jury to hear alleged financial crime motive
  • How the cases in Alex Murdaugh's murder trial are shaping up
  • Testimony: Maggie Murdaugh may have bought gun that killed her
More Life Insurance News

- Presented By -

Top Read Stories

  • Pennsylvania woman sentenced in elderly fraud case
  • NY man sentenced for operating a Ponzi scheme, stole more than $1M
  • For agents and advisors, dispelling LTCI myths is crucial to building sales
  • Fed slows interest rate increases; more hikes expected
  • Allstate reports $1.4B loss for 2022; increases rates, policy restrictions
More Top Read Stories >

FEATURED OFFERS

Meet Encova Life
We know agents matter. You can count on our life team to be high tech, high touch and responsive.

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Life Insurance News
  • Annuity News
  • Health/Employee Benefits
  • Property and Casualty
  • Advisor News
  • Washington Wire
  • Regulation News
  • Sponsored Articles
  • Monthly Focus

Top Sections

  • Life Insurance News
  • Annuity News
  • Health/Employee Benefits News
  • Property and Casualty News
  • AdvisorNews
  • Washington Wire
  • Insurance Webinars

Our Company

  • About
  • Editorial Staff
  • Magazine
  • Write for INN
  • Advertise
  • Contact

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2023 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • AdvisorNews

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.